#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic oesophagitis Wolfram syndrome Oropharyngeal cancer recurrent Pelizaeus-Merzbacher disease Breast angiosarcoma Loeys-Dietz syndrome Retinopathy proliferative Cystic fibrosis respiratory infection suppression Mitochondrial encephalomyopathy Cardiac failure acute Pleomorphic leiomyosarcoma Ovarian cancer Renal disorder Glomerulonephritis membranoproliferative Duchenne muscular dystrophy More trials…

    Learn about Rare Diseases

    Osteosarcoma – Treatment Alagille syndrome – Treatment Advanced systemic mastocytosis – Diagnostics Myelodysplastic syndrome with excess blasts – Life with Disease Synovial sarcoma – Basic Information Prolymphocytic leukaemia – Basic Information Ornithine transcarbamoylase deficiency – Trials in Disease Factor VIII deficiency – Trials in Disease Focal segmental glomerulosclerosis – Trials in Disease Pleomorphic leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taldefgrobep Alfa Xaluritamig Florbetapir (18F) Regn5668 Propofol Fosfomycin Clascoterone AVTX-009 Nemvaleukin Alfa TRIGLYCERIDES MEDIUM CHAIN HALOBETASOL PROPIONATE Dacarbazine Citrate COBALAMIN Cytarabine Lutetium (177Lu)-Neobomb1 ALE.P03 Bi-1808 Afatinib Follitropin Beta AZD1163 More therapies…

    Learn about Your Condition

    Nephropathy Kaposi's sarcoma Pneumococcal infection Haemolytic uraemic syndrome Small intestine leiomyosarcoma Elderly Medullary thyroid cancer Rosai-Dorfman syndrome Laryngeal leukoplakia Thyroid cancer HER2 positive gastric cancer Ichthyosis Angelman's syndrome Injury Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clinica Privada Dr. Barceló

Clinica Privada Dr. Barceló

Calle Pinzón, 10, Malaga, 29001, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

    Recruiting

    3 1
    Portugal Spain
  • Skin Prick Test Diagnostic Accuracy Study in Patients with Dermatophagoides pteronyssinus and Dermatophagoides farinae Allergy Using Dermatophagoides pteronyssinus Extract and Dermatophagoides farinae Extract

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Dermatophagoides Farinae Extract
    • Dermatophagoides Pteronyssinus Extract
    • Histamine Dihydrochloride
    Spain
  • Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!